Posts

Posted on

TIVITY HEALTH INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Tivity Health, Inc. – TVTY

TIVITY HEALTH INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Tivity Health, Inc. – TVTY

NEW ORLEANS–(BUSINESS WIRE)–
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Tivity Health, Inc. (NasdaqGS: TVTY).

On February 19, 2020, the Company announced its financial results for the fourth quarter and year ended December 31, 2019, disclosing that its “Nutrition segment had a disappointing end to 2019” including “a non-cash impairment charge of $377.1 million,” that contributed to a $272.8 million net loss in the fourth quarter, due to complications in the nutrition business since its acquisition of Nutrisystem in March 2019, and also that its Chief Executive Officer had resigned. In September of 2020, the Company announced the resignation of co-founder Daniel G. Tully from its Board of Directors. Then, in October of 2020, it was reported that the Company would be selling Nutrisystem for $575 million, less than half of what Tivity paid to buy it.

The Company and certain of its executives have been sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws, which remains ongoing.

KSF’s investigation is focusing on whether Tivity’s officers and/or directors breached their fiduciary duties to Tivity’s shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of Tivity shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-tvty/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner

[email protected]

1-877-515-1850

KEYWORDS: Louisiana United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo
Posted on

SHAREHOLDER ALERT: CLAIMSFILER REMINDS BSX, FAF, RTX, SPLK INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

NEW ORLEANS, Dec. 18, 2020 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:


First American Financial Corp. (FAF)


Class Period: 2/17/2017 – 10/22/2020
Lead Plaintiff Motion Deadline: December 24, 2020
SECURITIES FRAUD
To learn more, visit https://www.claimsfiler.com/cases/view-first-american-financial-corp-securities-litigation


Raytheon Technologies Corporation f/k/a Raytheon Company (RTX, RTN)


Class Period: 2/10/2016 – 10/27/2020
Lead Plaintiff Motion Deadline: December 29, 2020
SECURITIES FRAUD
To learn more, visit https://www.claimsfiler.com/cases/view-raytheon-technologies-corporation-securities-litigation  


Boston Scientific Corporation (BSX)


Class Period: 4/24/2019 – 11/16/2020
Lead Plaintiff Motion Deadline: February 2, 2021
SECURITIES FRAUD
To learn more, visit https://www.claimsfiler.com/cases/view-boston-scientific-corporation-securities-litigation-4


Splunk Inc. (SPLK)


Class Period: 10/21/2020 – 12/2/2020
Lead Plaintiff Motion Deadline: February 2, 2021
SECURITIES FRAUD
To learn more, visit https://www.claimsfiler.com/cases/view-splunk-inc-securities-litigation

If you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact us toll-free (844) 367-9658 or visit the case links above.

If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com



Posted on

WeissLaw LLP Reminds EIGI, GV, CGIX and ROCH Shareholders About Its Ongoing Investigations

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ —


If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:


Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025

(888) 593-4771
[email protected]

Endurance International Group Holdings, Inc. (NASDAQ: EIGI)  

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Endurance International Group Holdings, Inc. (NASDAQ: EIGI) in connection with the proposed acquisition of the company by affiliates of Clearlake Capital Group, L.P.  Under the terms of the agreement, EIGI shareholders will receive $9.50 per share in cash for each share of EIGI common stock that they hold.  If you own EIGI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://www.weisslawllp.com/EIGI/  

The Goldfield Corporation (NYSE American: GV)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of The Goldfield Corporation (NYSE American: GV) in connection with the proposed acquisition of the company by affiliates of First Reserve Fund XIV, L.P.  The transaction is structured as an all-cash tender offer in which the company’s shareholders will receive $7.00 for each share of GV common stock that they hold.  If you own GV shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://www.weisslawllp.com/GV/ 

Cancer Genetics, Inc. (NASDAQ: CGIX)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cancer Genetics, Inc. (NASDAQ: CGIX) in connection with the company’s proposed merger with privately-held StemoniX, Inc.  Under the terms of the agreement, CGIX will acquire all of the outstanding shares of StemoniX in exchange for approximately 78% of CGIX’s outstanding common stock.  The combined company will continue to trade on the NASDAQ, but CGIX shareholders will control only 22% of the surviving entity.  If you own CGIX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/cgix/

Roth CH Acquisition I Co. (NASDAQ: ROCH)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Roth CH Acquisition I Co. (NASDAQ: ROCH) in connection with the Company’s proposed merger with privately-held PureCycle Technologies LLC.  Under the terms of the agreement, ROCH will acquire PureCycle through a reverse merger that will result in PureCycle becoming a publicly-traded company.  If you own ROCH shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/news/roch/

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-reminds-eigi-gv-cgix-and-roch-shareholders-about-its-ongoing-investigations-301196321.html

SOURCE WeissLaw LLP

Posted on

SHAREHOLDER ALERT: WeissLaw LLP Reminds WTRE and STPK Shareholders About Its Ongoing Investigations

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ — 


If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:


Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025

(888) 593-4771
[email protected]

Watford Holdings Ltd. (NASDAQ: WTRE)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Watford Holdings Ltd. (NASDAQ: WTRE) in connection with the proposed acquisition of the company by Arch Capital Group Ltd.  Under the terms of the acquisition agreement, the company’s shareholders will be entitled to receive $31.10 in cash for each WTRE share they own.  If you own WTRE shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://www.weisslawllp.com/wtre/ 

Star Peak Energy Transition Corp. (NYSE: STPK)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Star Peak Energy Transition Corp. (NYSE: STPK) in connection with the company’s proposed merger with Stem Inc. (“Stem”).  Under the terms of the merger agreement, STPK will acquire Stem through a reverse merger that will result in Stem becoming a publicly-traded company.  If you own STPK shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/stpk/  

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-wtre-and-stpk-shareholders-about-its-ongoing-investigations-301196322.html

SOURCE WeissLaw LLP

Posted on

Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against GoodRx Holdings, Inc. – GDRX

Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against GoodRx Holdings, Inc. – GDRX

NEW YORK–(BUSINESS WIRE)–
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 to November 16, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for GoodRx investors under the federal securities laws.

To join the GoodRx class action, go to http://www.rosenlegal.com/cases-register-2011.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

The GoodRx class action lawsuit alleges that, at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. According to the GoodRx class action lawsuit, given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, their statements in the Registration Statement and during the Class Period about GoodRx’s competitive position were materially false and/or misleading when made and caused GoodRx Class A common stock to trade at artificially inflated prices of more than $64 per share during the Class Period.

Then on November 17, 2020, just weeks after GoodRx completed its IPO, Amazon announced two new pharmacy offerings, a Prime Rx plan and a discount card program, which, among other things, would compete directly with GoodRx’s platform by making it “simple for customers to compare prices and purchase medications for home delivery, all in one place.” In response to this news, the price of GoodRx Class A common stock declined 23%, from $46.72 per share to $36.21 per share by market close on November 17, 2020, damaging investors.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 16, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-2011.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo
Posted on

WeissLaw LLP Reminds CLCT, JWS, TGC, and TNAV Shareholders About Its Ongoing Investigations

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ —


If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:


Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

Collectors Universe, Inc.
 (NASDAQ: CLCT)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Collectors Universe, Inc. (NASDAQ: CLCT) in connection with the proposed acquisition of the company by an investor group led by entrepreneur and sports card collector Nat Turner, D1 Capital Partners L.P., and Cohen Private Ventures, LLC.  Under the terms of the agreement, the company’s shareholders will receive $75.25 in cash for each share of CLCT common stock that they hold.  If you own CLCT shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/clct/

Jaws Acquisition Corp. (NYSE: JWS)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Jaws Acquisition Corp. (NYSE: JWS) in connection with JWS’ merger with privately-held Cano Health, LLC (“Cano”).  Under the terms of the agreement, JWS will acquire Cano through a reverse merger that will result in Cano becoming a publicly-listed company.  If you own JWS shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/jws/  

Tengasco Inc. (NYSE: TGC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Tengasco Inc. (NYSE: TGC) in connection with the company’s proposed merger with privately-held Riley Exploration-Permian, LLC (“Riley”), pursuant to which TGC will issue shares of TGC common stock to Riley members and the new combined entity will trade under the new ticker symbol “REPX.”  If you own TGC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/tgc/ 

Telenav
, Inc. (NASDAQ: TNAV)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Telenav, Inc. (NASDAQ: TNAV) in connection with the proposed interested-party acquisition of the company by V99, Inc., a corporation led by TNAV’s President and CEO HP Jin.  TNAV shareholders will receive only $4.80 for each share of TNAV that they hold, which appears to significantly undervalue TNAV especially in light of the conflicts inherent in the transaction.  If you own TNAV shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/tnav/

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-reminds-clct-jws-tgc-and-tnav-shareholders-about-its-ongoing-investigations-301196319.html

SOURCE WeissLaw LLP

Posted on

SHAREHOLDER ALERT: WeissLaw LLP Reminds NGA, FIII, and SNSS Shareholders About Its Ongoing Investigations

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ — 


If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:


Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

Northern Genesis Acquisition Corp. (NYSE: NGA)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Northern Genesis Acquisition Corp. (NYSE: NGA) in connection with the company’s proposed merger with The Lion Electric Co.  Under the terms of the merger agreement, NGA will acquire Lion Electric Co. through a reverse merger that will result in Lion Electric Co. becoming a publicly-traded company.  If you own NGA shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://www.weisslawllp.com/nga/ 

Forum Merger III Corporation (NASDAQ: FIII)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Forum Merger III Corporation (NASDAQ: FIII) in connection with the company’s proposed merger with Electric Last Mile, Inc. (“ELMI”). Under the terms of the merger agreement, FIII will acquire ELMI through a reverse merger that will result in ELMI becoming a publicly-traded company.  If you own FIII shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/fiii/  

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) in connection with the company’s proposed merger with Viracta Therapeutics, Inc. (“Viracta”)  Under the terms of the merger agreement, SNSS and Viracta will combine, resulting in current Viracta stockholders owning 86% of the post-close company and leaving only 14% of the surviving entity to current SNSS stockholders.  If you own SNSS shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/snss/

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-nga-fiii-and-snss-shareholders-about-its-ongoing-investigations-301196316.html

SOURCE WeissLaw LLP

Posted on

SHAREHOLDER ALERT: WeissLaw LLP Reminds DMYD, EIDX, IPHI, and MCAC Shareholders About Its Ongoing Investigations

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ —


If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:


Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

dMY Technology Group, Inc. II (NYSE: DMYD)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of dMY Technology Group, Inc. II (NYSE: DMYD) in connection with the company’s proposed merger with Genius Sports Group Limited (“GSG”).  Under the terms of the agreement, DMYD will acquire GSG through a reverse merger that will result in GSG becoming a public company.  If you own DMYD shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/dmyd/   

Eidos Therapeutics, Inc. (NASDAQ: EIDX)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Eidos Therapeutics, Inc. (NASDAQ: EIDX) in connection with the proposed interested-party acquisition of the company by BridgeBio Pharma, Inc. (“BridgeBio”).  Under the terms of the agreement, EIDX shareholders can elect to receive either 1.85 shares of BridgeBio or $73.26 for each share of EIDX common stock that they own, subject to proration such that the aggregate cash portion will not exceed $175 million.  Notably, an active alternative bidder offering nearly $50.00/share more is currently being frozen out and prevented from engaging with EIDX.  If you own EIDX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/eidx/

Inphi Corporation (NASDAQ: IPHI)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Inphi Corporation (NASDAQ: IPHI) in connection with the company’s proposed merger with Marvell Technology Group Ltd. (“MRVL”).  Under the terms of the agreement, IPHI shareholders will receive $66.00 in cash and 2.323 shares of the newly-combined company for each IPHI share that they own.  If you own IPHI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/iphi/ 

Mountain Crest Acquisition Corp. (NASDAQ: MCAC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Mountain Crest Acquisition Corp. (NASDAQ: MCAC) in connection with the company’s proposed merger with privately-held Playboy Enterprises, Inc. (“Playboy”).  Under the terms of the agreement, MCAC will acquire Playboy through a reverse merger that will result in Playboy becoming a publicly-traded company.  If you own MCAC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/news/mcac/

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-dmyd-eidx-iphi-and-mcac-shareholders-about-its-ongoing-investigations-301196312.html

SOURCE WeissLaw LLP

Posted on

SHAREHOLDER ALERT: WeissLaw LLP Investigates Deerfield Healthcare Technology Acquisitions Corp.

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Deerfield Healthcare Technology Acquisitions Corp. (“DFHT” or the “Company”) (NASDAQ: DFHT) in connection with the Company’s proposed merger with CareMax Medical Group, LLC (“CareMax”) and IMC Medical Group Holdings, LLC (“IMC Health”), privately-held technology-enabled providers of value-based care to seniors.  Under the terms of the merger agreement, DFHT will acquire CareMax and IMC Health through a reverse merger.  At close of the transaction, DFHT expects to be renamed CareMax, Inc. and will remain listed on the NASDAQ stock market under a new ticker symbol.


If you own DFHT shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:


https://www.weisslawllp.com/DFHT/


Or please contact:



Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

WeissLaw is investigating whether DFHT’s board acted in the best interest of DFHT’s public shareholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of CareMax and IMC Health, and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to DFHT public shareholders. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-deerfield-healthcare-technology-acquisitions-corp-301196309.html

SOURCE WeissLaw LLP

Posted on

Anything Technologies Media, Inc. and Minerco, Inc. Host the World’s First “Shroom Zoom” CNN Viewing

Prior to Watching the CNN Live Special, Dr. Sheba Roy ND FABNO, Will Discuss the Emerging Data Potential Health Benefits of Psilocybin and CBD via Zoom

TUCSON, AZ, Dec. 18, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Anything Technologies Media, Inc. (OTC:EXMT) and Minerco, Inc. (OTC:MINE) announced today that they partnered to provide the first ever “Shroom Zoom” Viewing and Q&A regarding the potential health benefits of Psilocybin and CBD.

Join us a 9:00 pm EST on Sunday, December 20th for an exciting and dynamic Zoom presentation by Dr. Sheba Roy, a supportive care cancer specialist with Associates of Integrative Medicine in Michigan. Dr. Roy’s clinic hosts masters and doctoral level counselors who treat Trauma, PTSD, Depression, Anxiety, Grief and Loss using a powerful combination of therapeutic counseling, nutrition and natural therapies.

We will follow the discussion with a Zoom Viewing of the CNN live special, “Psychedelic Healing”, hosted at 10 pm EST by Lisa Ling https://www.cnncreativemarketing.com/project/thisislife/. This is Life with Lisa Ling is a groundbreaking documentary series that shines the light on what were formally considered “taboo” topics and how they can change the way we think about ourselves and the world around us. December 20th’s feature will highlight the emerging science around of psilocybin and CBD in the treatment of mental health issues and goals of optimal wellness.

Following the CNN live special, we will host a live Q&A session with Dr. Roy by Zoom. Minerco, Inc. and Anything Technologies Media are committed to offering our communities extraordinary opportunities to be at the leading edge of transformational healing.

Watch with us and register below:

https://zoom.us/meeting/register/tJYod-mvqTotGdJuRrBhoodPnOWLnYPhA0iv

About Anything Technologies Media, Inc. (OTC:EXMT)

Anything Technologies Media is a manufacturing and marketing company involved in the sales and marketing of CBD Health products and software applications. ATM is the parent company of subsidiary Corporations and is focused on partnerships and acquisitions in new technologies and manufacturing sectors. The company and partners each have their own professional management team with extensive backgrounds in finance, manufacturing, marketing and distribution. ATM’s goal is to combine the expertise of our team members to create a cohesive force, which will carry the company forward in the marketplace.

About Minerco, Inc. (OTC:MINE)

Minerco, Inc. (OTC:MINE), was recently acquired by a psilocybin research and investment firm and is emerging as the world’s first publicly traded company focused on the research, production and distribution of psilocybin mushrooms. Also, MINE has developed Blockchain Token SHRU to create a payment gateway for retail purchases.

Please follow https://twitter.com/minercoinc

Investor Relations

[email protected]

About Sonoran Flower LLC.

https://sonoranflower.com/store

Sonoran Flower was built on the belief that nature holds everything we need to heal. We are a multifaceted organization that cultivates, processes, and sells wholesale and retail hemp goods. We procure and produce top-quality hemp seeds, smokable hemp flower, hemp biomass, distillates, isolates and products such as vape, lotions, salves, and Hemp Beverage.

To purchase Sonoran Flower CBD Products call 520-303-HEMP (4367)

Follow us on Twitter @
https://twitter.com/anythingtechmed

Follow us on Instagram @
https://www.instagram.com/anythingcbdmeds/

About Amethyst Beverage:
https://www.amethystbeverage.com/

Amethyst Beverage, a Reno, NV based business, was established in October 2016 mostly as a directive to support a Philanthropy effort toward Cancer associated with Children and Adults. A portion of all sales will be contributed to several organizations nationally.

Currently, Amethyst Beverage is the only water in the marketplace to carry Patented, USDA Organic, Vegan and Kosher certifications, and is also the only flavored (Strawberry/Watermelon, Orange/Mango, Pineapple/Coconut, Cran/Razz, Cucumber/Mint and Peach) alkaline water with fulvic acid containing 70 ionic minerals as well.

Safe Harbor Statement

Certain statements made in this press release constitute forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

Anything Technologies Media, Inc.
[email protected]